NENora Yousry Elsaid

Nora Yousry Elsaid

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nora Yousry Elsaid has a total of 89 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Auditory P300 as a neurophysiological marker of cognitive impairment in fibromyalgia syndrome

    by Dina Osman, Sarah Sheta, Nora Elsaid, Esraa Seif ElDin

    Background: Cognitive dysfunction has become a well-recognized clinical feature of fibromyalgia syndrome. Although subjective cognitive complaints are frequently reported, objective neurophysiological assessments remain limited. Auditory P300 event related potentials may provide an objective measure of altered cognitive processing in FM patients. OBJECTIVES: To evaluate cognitive performance in fibromyalgia patients and analyze the association between cognitive affection and determine the relationship with disease duration and the severity. Methods: A total of 30 adult fibromyalgia patients were enrolled in this study. Participant underwent detailed clinical evaluation, including medical history taking, basic audiological assessment, disease severity evaluation using the Fibromyalgia Impact Questionnaire (FIQR), P300, mini mental state examination (MMSE). The obtained findings were compared with age and gender matched controls. Results: Compared with healthy controls, patients demonstrated significantly lower MMSE scores, prolonged P300 latency, and reduced P300 amplitudes. P300 latency showed significant correlations with MMSE and FIQR scores. P300 latency demonstrated the highest discriminatory performance among investigated parameters in differentiating FM patients from healthy controls. Conclusions: Fibromyalgia patients exhibited measurable differences in cognitive performance compared with healthy controls. These findings support the presence of altered cognitive processing in FM patients and suggest that P300 may be a promising objective neurophysiological measure of cognitive function.

  • Open Access

    Systemic Sclerosis and Abortion: Determining Factors and Clinical Significance in a Multicenter Study

    by Tamer A. Gheita, Hanan El-Saadany, Fatma Ali, Gehad Maghraby, Nermeen Noshy, Rawhya R. El-Shereef, Nesrin Aboeladl, Eman F. Mohamed, Enas A. Abdelaleem, Samar Tharwat, et al.

    Objective: The aim of this work was to identify disease-related factors associated with a history of spontaneous abortion in adult female patients with systemic sclerosis (SSc), and to further analyze the distinguishing features of SSc patients with recurrent versus single abortion episodes. Materials and Methods: This multicenter case-control study was extracted from a nationwide SSc cohort of 1,080 patients. Ninety-one female adult SSc patients (8.4%) with a history of spontaneous abortion before 20 completed weeks of gestation were compared with 91 age-matched female SSc patients without a history of spontaneous abortion. Clinical characteristics, comorbidities, organ involvement, medications, and laboratory parameters were analyzed. Results: Patients with spontaneous abortion had significantly longer disease duration (6.4±4.7 vs . 4.6±4.2 years; p =0.007), a higher prevalence of comorbidities (29.7% vs . 15.4%; p =0.03), more frequent telangiectasia (28.6% vs . 12.1%; p =0.009) and a higher frequency of mycophenolate mofetil use (29.7% vs . 15.4%; p =0.03) compared with patients without a history of spontaneous abortion. Recurrent spontaneous abortion occurred in 30 patients (33.0%). Compared with those with a single spontaneous abortion, patients with recurrent spontaneous abortion had significantly higher frequencies of Raynaud’s phenomenon ( p p =0.047), hypo-/hyperpigmentation ( p =0.03), cardiovascular involvement ( p =0.046), anti-Scl-70 positivity ( p =0.01), double autoantibody positivity ( p =0.017), and higher serum triglyceride levels ( p =0.006). Discussion: Patients with SSc have a higher risk of spontaneous abortion than the general population; this risk is likely driven by decidual vasculopathy and fibrosis. Factors contributing to spontaneous abortion were variable in previous reports, with hypertension and long disease duration among the most contributing factors. Conclusion: In women with SSc, spontaneous abortion is associated with longer disease duration, telangiectasia, higher serum creatinine levels, the presence of comorbidities, and the use of MMF. Recurrent spontaneous abortion is associated with anti-Scl-70 positivity, double autoantibody positivity, and hypertriglyceridemia.

  • Open Access

    Frequency and Impact of Bipolar Disorder Types in Patients with Fibromyalgia

    by Hanan A Kotb, Fatma M Noureldin, Doaa R Ayoub, Nora Yousry Elsaid

    Background: Fibromyalgia (FM) is a rheumatic illness that is characterised by widespread chronic pain, fatigue and psychiatric disorders, including depression and bipolar disorders, which may occur concomitantly with FM. Aim of the Work: To evaluate the frequency of bipolar disorder types in FM patients and to assess the impact of their types on the functional status. Patients and Methods: This study enrolled 55 female patients with FM and 55 age and sex-matched controls. Functional status was evaluated using the Fibromyalgia Impact Questionnaire (FIQ). All participants were assessed for psychiatric disorders using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), the Hamilton Depression rating scale (HDRS), the Young Mania Rating Scale (YMRS) and the Hypomania Symptom Checklist (HCL-32). Results: Bipolar disorder II was diagnosed in 12.7% of FM patients but in none of the control group. According to SCID-I, irritability as a symptom of a hypomanic episode was more frequent in FM ( n = 39, 70.9%) patients versus two (3.6%) controls ( P < .0001). Dysthymic disorder symptoms were reported only in FM ( n = 21, 38.1%). Only one FM patient reported delusions and psychotic symptoms. Depression was diagnosed with 78.2% of FM patients, compared to 7.3% of controls ( P < .0001). Hypomanic symptoms were present in 72.7% of FM patients and in 3.2% controls only ( P < .0001). There was a significant correlation between the FIQ and mood disorders and hypomania ( P < .0001, P < .02). Conclusion: Bipolar disorder II is more frequent in FM patients than in healthy controls, contributing to the exacerbation of the disease symptoms and increased functional impairment.

  • Open Access

    Takayasu Arteritis with Neurological Manifestations: Clinical and Neurovascular Imaging Characteristics

    by Amira A. Shahin, Hania S. Zayed, Shereen Fathi, Nora Y. Elsaid

    Background: Takayasu arteritis (TA) is a large vessel vasculitis that may be accompanied by neurologi cal involvement in 57%-80% of the patients. The aim of this work is to describe the clinical and neuro vascular imaging abnormalities in TA patients with neurological manifestations. Methods: Thirty-nine TA patients with neurological manifestations and available brain magnetic reso nance imaging (MRI), MR angiography (MRA), and MR venography of the intracranial and cervical vessels were studied. Patients with thrombophilia or hyperlipidemia were excluded. Results: The mean age at TA diagnosis was 30.56 ± 8.74 years, and 33 (84.62%) of the patients were women. The most frequent neurological manifestations included headaches (64.1%), syncope (12.8%), and visual loss (10.26%). According to the angiographic classification, 37 (94.9%) of the patients had involvement of branches from the aortic arch (Type I), and only 2 (5.1%) had diffuse aortic involve ment (Type V). Steno-occlusive lesions of the medium-sized intracranial arteries were observed in 11 (28.21%) of the patients. Features suggestive of small vessel disease were found among 16 (41%); 13 had abnormal MRI findings and 3 other patients had normal MRI and increased collateral circulation on MRA without associated intracranial arterial stenosis. Opening of the collateral circulation was seen in 14 (35.9%) patients. Venous involvement (affecting the cerebral venous sinuses and jugular veins) was found in 12 (30.77%) patients. Conclusion: Patients with TA and neurological manifestations exhibit a spectrum of extracranial and intracranial vascular abnormalities including large, medium, and small blood vessels, as well as the cerebral venous sinuses and jugular veins. Cite this article as: Shahin AA, Zayed HS, Fathi S, Elsaid NY. Takayasu arteritis with neurological manifestations: clinical and neurovascular imaging characteristics. Eur J Rheumatol. 2025, 12(4), 0003, doi:10.5152/eurjrheum.2025.25003.


  • Delay in diagnosis in Egyptian axial spondylarthritis patients, contributing factors and worldwide stance

    by Nora Y. Elsaid, Sherif M. Gamal, Sarah A. Sakr, Wafaa H. Hussein

    Objectives. Among all rheumatic diseases, axial spondyloarthritis (axSpA) has one of the longest delays between the onset of symptoms and diagnosis. This study aimed to investigate the diagnostic delay in a cohort of Egyptian axSpA patients, specifically the time between symptom onset and access to rheumatology care. Additionally, we aimed to analyze the factors associated with this delay and compare it to diagnostic delays observed in different countries and regions around the world. Material and methods. This cross-sectional study included 51 axSpA patients diagnosed according to the Assessment of Spondyloarthritis International Society (ASAS) criteria. All participants underwent a comprehensive assessment including history taking, clinical examination, review of laboratory and radiological investigations, and treatment. Activity and functional indices were also applied. We conducted correlative studies to analyze factors associated with the delay in diagnosis. Participants were divided into two groups: early diagnosis and late diagnosis, with a cutoff of 5 years. The two groups were compared regarding demographic data, clinical findings, activity, and functional indices. Relations between the groups were assessed using the independent samples t-test or Mann-Whitney’s test for numerical variables. Results. The median (IQR) diagnostic delay was 7 years (3-10 years). Patient age was significantly correlated with diagnostic delay (P = 0.004). Comparison of the early and late diagnosis groups revealed that older patients were more likely to receive an earlier diagnosis. Conclusions. A significant delay in the diagnosis of axSpA persists among Egyptian patients. This delay is correlated with disease duration and is more likely to occur when non-rheumatologists are consulted first.

  • Open Access

    Rheumatoid arthritis study of the Egyptian College of Rheumatology (ECR): nationwide presentation and worldwide stance

    by Tamer A. Gheita, Hala A. Raafat, Samah A. El-Bakry, Ahmed Elsaman, Hanan M. El-Saadany, Nevin Hammam, Iman I. El-Gazzar, Nermeen Samy, Nora Y. Elsaid, Suzan S. Al-Adle, et al.

    To depict the spectrum of rheumatoid arthritis (RA) in Egypt in relation to other universal studies to provide broad-based characteristics to this particular population. This work included 10,364 adult RA patients from 26 specialized Egyptian rheumatology centers representing 22 major cities all over the country. The demographic and clinical features as well as therapeutic data were assessed. The mean age of the patients was 44.8 ± 11.7 years, disease duration 6.4 ± 6 years, and age at onset 38.4 ± 11.6 years; 209 (2%) were juvenile-onset. They were 8750 females and 1614 males (F:M 5.4:1). 8% were diabetic and 11.5% hypertensive. Their disease activity score (DAS28) was 4.4 ± 1.4 and health assessment questionnaire (HAQ) 0.95 ± 0.64. The rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) were positive in 73.7% and 66.7% respectively. Methotrexate was the most used treatment (78%) followed by hydroxychloroquine (73.7%) and steroids (71.3%). Biologic therapy was received by 11.6% with a significantly higher frequency by males vs females (15.7% vs 10.9%, p = 0.001). The least age at onset, F:M, RF and anti-CCP positivity were present in Upper Egypt (p < 0.0001), while the highest DAS28 was reported in Canal cities and Sinai (p < 0.0001). The HAQ was significantly increased in Upper Egypt with the least disability in Canal cities and Sinai (p = 0.001). Biologic therapy intake was higher in Lower Egypt followed by the Capital (p < 0.0001). The spectrum of RA phenotype in Egypt is variable across the country with an increasing shift in the F:M ratio. The age at onset was lower than in other countries.


  • Rheumatologists’ knowledge and perception of COVID-19 and related vaccines: the vaXurvey2 online survey

    by Hanan M. Fathi, Iman I. El Gazzar, Mervat I. Abd Elazeem, Enas AboulKheir, Nada M. Gamal, Faten Ismail, Rawhya R. El Shereef, Samar Tharwat, Shereen Elwan, Nermeen Samy, et al.

    The study aimed to explore the experience of coronavirus disease-2019 (COVID-19) infection and vaccine adverse events (AEs) among rheumatologists. A validated questionnaire was distributed as a Google form to rheumatologists across the country via social networking sites from late December 2021 till early January 2022. The questionnaire included questions regarding participants' socio-demographic details, COVID-19 infection and vaccination details with special emphasis on AEs. Out of 246 responses, 228 were valid. 200 (81.3%) responders had received the vaccine. The mean age of the 228 participants was 37.9 ± 8.5 years, 196 were females and 32 males (F:M 6.1:1) from 18 governorates across the country. Comorbidities were present in 54 subjects (27%). There was a history of highly suspicious or confirmed COVID-19 infection in 66.7% that were all managed at home. The COVID-19 vaccine was received by 200 and a booster dose of 18.5%. Obesity and musculoskeletal involvement co-morbidities were present only in those with AEs (9.1% and 5.5% respectively). AEs were present in 82%; 66.7% had injection-site tenderness, 50% fatigue, 35.5% fever, 15% chills, 42.5% myalgia, 14.5% arthralgia, 8% low back pain, headache 31%, dizziness 10%, sleepliness 16% and 15% developed post-vaccine. There were no differences according to the geolocation regarding the occurrence of COVID-19 infection (p = 0.19) or AEs post-vaccine (p = 0.58). The adverse events were mostly mild to moderate and tolerable which makes this work in agreement with other studies that support the broad safety of the vaccine in favor of the global benefit from mass vaccination.


  • Open Access

    Disease characteristics in patients with juvenile- and adult-onset systemic lupus erythematosus: A multi-center comparative study

    by Sherif M Gamal, Nermeen Fouad, Nora Yosry, Wael Badr, Nesreen Sobhy

    Objectives: This study aims to compare disease characteristics in patients with juvenile-onset systemic lupus erythematosus (JSLE) and adult-onset systemic lupus erythematosus (ASLE). Patients and methods: Between June 2010 and March 2020, a total of 186 patients with JSLE (23 males, 163 females; median age: 25 years; range, 20 to 30.3 years) and 236 patients with ASLE (23 males, 213 females; median age: 35 years; range, 29 to 40 years) were retrospectively analyzed. Clinical and laboratory data, treatment received, Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) and Systemic Lupus International Collaborating Clinics (SLICC)/ACR Damage Index (SDI) scores, comorbidities and deaths were compared between the groups. Results: The JSLE patients showed statistically significant higher constitutional manifestations, cardiac manifestations, serositis, nephritis, end-stage renal disease, neurological manifestations, gastrointestinal manifestations, secondary vasculitis, Raynaud’s, livedo-reticularis, dry mouth, dry eye, ocular manifestations, avascular necrosis, hematological manifestations, and hypocomplementemia (p


  • Open Access

    Overlap between systemic sclerosis and polyarteritis nodosa: A case report

    by Geilan A. Mahmoud, Nora Y. Elsaid, Hania S. Zayed